Multicenter segmentectomy in VR
- Conditions
- ung carcinoma (NSCLC), benign pathologie (bronchiectasis, hamartoma) or metastatic pulmonary lesion
- Registration Number
- NL-OMON27754
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Indication for lung segment resection. Patient older than 18 years, operation planned in one of participating centers. Diagnostic CT thorax with max slide width of 1,5mm available. (High suspicion of ) lung carcinoma NSCLC stage 1A1/1A2 (cT1a/bN0M0) not centrally located and suitable for segment resection, or benign pathology (ie hamartoma) suitable for segment resection, or metastatic pulmonary lesion (extra thoracic origin or reoccuring lung carcinoma) suitable for segment resection
Exclusion Criteria
No informed consent for using VR as preoperative tool, patient wish for lobectomy instead of segmentectomy, not suitable for segmentectomy based on preoperative screening
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Additional value of advanced imaging (based on 3D-VR and AI technology) over 2D-CT
- Secondary Outcome Measures
Name Time Method Percentage change of plan due to 3D-VR planning, percentage more lung sparing, preoperative planning time of 3D-VR and 2D-CT, consensus between different participating centers. Similarities between parameters in 3D-VR and real-life, Ease-of-use of 3D-VR software, perioperative outcomes of VR-guided segmentectomies.